Which anesthetic agent interferes least with electrocorticography (ECoG) recordings during surgery: dexmedetomidine, ketamine, nitrous oxide, sevoflurane, or midazolam?

Dexmedetomidine Interferes Least with ECoG Surgery

Dexmedetomidine is the optimal anesthetic agent for electrocorticography (ECoG) during epilepsy surgery, as it enhances or maintains spike activity in the majority of patients, while ketamine, nitrous oxide, sevoflurane, and midazolam all suppress epileptiform activity and should be avoided during critical ECoG recording periods.

Evidence Supporting Dexmedetomidine

Enhancement of Epileptiform Activity

• Dexmedetomidine actively enhances spike generation during intraoperative ECoG, with 67.6% of patients showing increased spike rates and only 20.6% showing >25% reduction in spike frequency 1
• The mean spike rate during dexmedetomidine infusion (1 μg/kg) was significantly higher compared to pre-dexmedetomidine phases (p=0.007 for maximum channel recordings) 1
• Dexmedetomidine at plasma concentrations of 0.48-1.60 ng/mL decreased median ECoG frequency but critically did not suppress spike activity in patients with temporal lobe epilepsy under sevoflurane anesthesia 2

Unique Mechanism of Action

• Unlike other sedatives, dexmedetomidine allows patients to return to baseline consciousness when stimulated, facilitating intraoperative assessment while maintaining adequate sedation 3
• Dexmedetomidine produces less respiratory depression than other sedative agents, reducing anesthetic-related complications 3

Agents to Avoid During ECoG Recording

Nitrous Oxide - Strongly Contraindicated

• Nitrous oxide significantly suppresses ECoG activity when added to either isoflurane or propofol-based anesthesia (p≤0.01) 4
• The addition of nitrous oxide to anesthetic regimens consistently depressed ECoG scores across multiple studies 4
• A systematic review explicitly recommends avoiding nitrous oxide due to undesired suppressive effects on epileptiform activity 5

Sevoflurane - Suppresses Epileptiform Activity

• Sevoflurane at 2.5% end-tidal concentration provides the background anesthesia in many studies, but switching from sevoflurane to TIVA (propofol) is necessary when both ECoG and motor evoked potential monitoring are required 6
• There is inadequate or conflicting evidence to support using sevoflurane during critical ECoG recording periods 5
• The evidence suggests sevoflurane may attenuate epileptiform activity, necessitating anesthetic switching strategies 6

Midazolam - Suppresses Cortical Activity

• Midazolam causes respiratory depression and suppresses cortical electrical activity, which is a major concern during epilepsy surgery 3
• The systematic review provides evidence to avoid midazolam due to undesired suppressive effects on ECoG recordings 5
• Midazolam's GABA-ergic mechanism inherently suppresses epileptiform discharges, making it unsuitable for ECoG-guided surgery 3

Ketamine - Contraindicated

• Ketamine should be avoided during ECoG recording due to undesired effects on epileptiform activity 5
• While ketamine has analgesic properties and maintains cardiovascular stability, its effects on cortical electrical activity make it unsuitable for epilepsy surgery requiring ECoG guidance 3

Practical Implementation Strategy

Anesthetic Protocol for ECoG Surgery

1. Induction phase: Use propofol or thiopental for induction, then maintain with oxygen-N₂O-isoflurane until surgical exposure 1

2. Pre-ECoG preparation: Decrease end-tidal MAC of N₂O and isoflurane to zero; maintain anesthesia with O₂:Air (50:50), vecuronium, and fentanyl 1, 7

3. ECoG recording phase: Administer dexmedetomidine 1 μg/kg infusion over 10 minutes, then maintain at 0.2 μg/kg/h 3, 1

4. Recording window: Begin ECoG recording 5 minutes after starting dexmedetomidine infusion for optimal spike enhancement 1

Critical Caveats

• Hemodynamic monitoring is essential: Dexmedetomidine causes transient bradycardia (10% of patients) and hypotension (21% of patients), though changes remain within physiological limits 3, 7
• The biphasic cardiovascular effect includes initial blood pressure increase (5-10 minutes) followed by 10-20% decrease 3
• Recovery time is longest with dexmedetomidine (85 minutes) compared to other agents, requiring appropriate planning for postoperative care 3

Alternative Strategy When MEP Monitoring Required

• If motor evoked potential (MEP) monitoring is needed alongside ECoG, use TIVA with propofol initially, switch to sevoflurane (2.5% end-tidal) for ECoG recording, then switch back to TIVA for MEP monitoring during resection 6
• This switching technique accommodates both neurophysiological monitoring requirements while optimizing recording quality 6